Ö. F. TABAK Et Al. , "Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey," AASLD - TASL CONNECT REGIONAL MEETING , 2019
TABAK, Ö. F. Et Al. 2019. Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey. AASLD - TASL CONNECT REGIONAL MEETING .
TABAK, Ö. F., KURTARAN, B., ZERDALİ, E., Tosun, S., ESEN, Ş., TÜRKER, K., ... SARI, N.(2019). Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey . AASLD - TASL CONNECT REGIONAL MEETING
TABAK, ÖMER Et Al. "Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey," AASLD - TASL CONNECT REGIONAL MEETING, 2019
TABAK, ÖMER F. Et Al. "Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey." AASLD - TASL CONNECT REGIONAL MEETING , 2019
TABAK, Ö. F. Et Al. (2019) . "Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey." AASLD - TASL CONNECT REGIONAL MEETING .
@conferencepaper{conferencepaper, author={ÖMER FEHMİ TABAK Et Al. }, title={Direct acting antivirals are effective and safe in intravenous drug users with chronic HCV Preview of your abstract file infection: First report from Turkey}, congress name={AASLD - TASL CONNECT REGIONAL MEETING}, city={}, country={}, year={2019}}